# |
PMID |
Sentence |
1 |
44619
|
Among fractioned components of IMP, IMP-1, IMP-2, and imp-3, by gel filtration with Sephadex G-200, all of the mice immunized with IMP-1 antigen alone or together with FCA and challenged on day 5 were able to conquer intraperitoneal challenges with 1 x10(2) parasites.
|
2 |
44619
|
Mice immunized with IMP-2 or IMP-3 died within 6 days after challenge.
|
3 |
44619
|
Moreover, protection efficacy shown by IMP-1p (144,000 xg sediment of IMP-1) antigen in mice was similar to that by IMP and IMP-1 antigens.
|
4 |
44619
|
No precipitin line was identified between mouse anti-IMP serum and IMP-1 or IMP-2.
|
5 |
44619
|
Among fractioned components of IMP, IMP-1, IMP-2, and imp-3, by gel filtration with Sephadex G-200, all of the mice immunized with IMP-1 antigen alone or together with FCA and challenged on day 5 were able to conquer intraperitoneal challenges with 1 x10(2) parasites.
|
6 |
44619
|
Mice immunized with IMP-2 or IMP-3 died within 6 days after challenge.
|
7 |
44619
|
Moreover, protection efficacy shown by IMP-1p (144,000 xg sediment of IMP-1) antigen in mice was similar to that by IMP and IMP-1 antigens.
|
8 |
44619
|
No precipitin line was identified between mouse anti-IMP serum and IMP-1 or IMP-2.
|
9 |
44619
|
Among fractioned components of IMP, IMP-1, IMP-2, and imp-3, by gel filtration with Sephadex G-200, all of the mice immunized with IMP-1 antigen alone or together with FCA and challenged on day 5 were able to conquer intraperitoneal challenges with 1 x10(2) parasites.
|
10 |
44619
|
Mice immunized with IMP-2 or IMP-3 died within 6 days after challenge.
|
11 |
44619
|
Moreover, protection efficacy shown by IMP-1p (144,000 xg sediment of IMP-1) antigen in mice was similar to that by IMP and IMP-1 antigens.
|
12 |
44619
|
No precipitin line was identified between mouse anti-IMP serum and IMP-1 or IMP-2.
|
13 |
22310204
|
The results showed that the group immunized with pcDNA-IMP1 developed a high level of specific antibody responses against Escherichia coli expressed recombinant TgIMP1, with high IgG antibody titers, predominance of IgG2a production, a strong lymphoproliferative response, and significant levels of IFN-γ, IL-2, IL-4 and IL-10 production compared with the control groups.
|